Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Herantis Pharma as an Investment | Life Science Night Dec 9, 2025

By Inderes
Herantis Pharma

Antti Vuolanto, CEO, talks about biotechnology company Herantis Pharma as an investment.


Life Science Night 2025

  • Keynote – Antti Siltanen, Inderes (link)
  • Orion Pharma – Tuukka Hirvonen, Head of Investor Relations (link)
  • Aiforia – Jukka Tapaninen, CEO (link)
  • Herantis Pharma – Antti Vuolanto, CEO (link)


Life Science Night December 9, 2025 (link)
Life Science Night December 2, 2024 (link)

Stay up to date
Investor events

Recent videos

HCA Morgenbørs 26/03 - Røde futures fra morgenstunden
26.03.2026, 09.19 SP Group
Kreate - Varsinainen Yhtiökokous 2026
26.03.2026, 09.00 Kreate Group
Asmodee, Webcast, Press Conference, 2026
26.03.2026, 08.30 Asmodee
SP Group – Presentation of the annual report for 2025
25.03.2026, 15.00 SP Group
Pharma Equity Group – Præsentation af årsregnskabet for 2025
25.03.2026, 14.00 Pharma Equity Group
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.